Presentation TCT 2016 Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Jonathan M. Hill October 31, 2016
Presentation TCT 2016 Clinical Risk Assessment and Health Status Goals in the CHIP Population Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Adam C. Salisbury October 31, 2016
Presentation TCT 2016 Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: An Early Career Perspective - A Dedicated Fellowship Is Necessary for New Trainees to Get Into the CHIP Space! Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert F. Riley October 31, 2016
Presentation TCT 2016 Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: A Mid-Career Perspective - On-the-job Training With Proctoring Is the Most Reliable Method! Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses October 31, 2016
Presentation TCT 2016 Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together? Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert W. Yeh October 31, 2016
Presentation TCT 2016 Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses October 31, 2016
Presentation TCT 2016 Case #4: Patent but Diseased SVG Used as a Conduit for Salvaging the Native Circulation Presenter: Barry D. Rutherford, Gerard T. Wilkins, Colm Hanratty October 30, 2016
Presentation TCT 2016 Case #3: SVG Occlusion With Heavily Calcified Native Vessel CTO With Viable Myocardium Presenter: Barry D. Rutherford, Gerard T. Wilkins, Masahisa Yamane October 30, 2016
Presentation TCT 2016 Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF Presenter: Barry D. Rutherford, Gerard T. Wilkins, James M. McCabe October 30, 2016
Presentation TCT 2016 Case #1: LIMA-LAD Anastomotic Lesion With Heavily Calcified Native LAD Lesion Presenter: Barry D. Rutherford, Gerard T. Wilkins, David E. Kandzari October 30, 2016
Presentation TCT 2015 New Approaches for Diffuse Disease: DEB, BRS, and Beyond Presenter: Jeffrey W. Moses, Erick Schampaert, Giuseppe Tarantini October 14, 2015
Presentation TCT 2015 SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead? Presenter: Jeffrey W. Moses, Erick Schampaert, Dimitri Karmpaliotis October 14, 2015
Presentation TCT 2015 Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized! Presenter: Jeffrey W. Moses, Erick Schampaert, Nabil Dib October 14, 2015
Presentation TCT 2015 Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly! Presenter: Jeffrey W. Moses, Erick Schampaert, Gert Richardt October 14, 2015
Presentation TCT 2015 Atheroablation: Current Technologies and Techniques Presenter: Jeffrey W. Moses, Erick Schampaert, Mohamed Abdel-Wahab October 14, 2015
Presentation TCT 2015 CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat Presenter: Jeffrey W. Moses, Erick Schampaert, Barry D. Rutherford October 14, 2015
Presentation TCT 2015 Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach Presenter: Jeffrey W. Moses, Erick Schampaert October 14, 2015
Presentation TCT 2015 Just How Effective Is Hypothermia in Cardiac Arrest? Presenter: Tanveer Rab, Holger Thiele, Michel R. Le May October 14, 2015
Presentation TCT 2015 The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock Presenter: Tanveer Rab, Holger Thiele October 14, 2015
Presentation TCT 2015 Escalation Therapies and RV Dysfunction: New Opportunities Presenter: Tanveer Rab, Holger Thiele, Navin K. Kapur October 14, 2015